Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989;28(Suppl 2):141S–149S. doi: 10.1111/j.1365-2125.1989.tb03589.x

Angiotensin and the remodelling of the myocardium

K T Weber, J S Janicki
PMCID: PMC1379855  PMID: 2690905

Abstract

1 From a morphologic standpoint, the myocardium has three compartments: cardiac myocytes; intramyocardial coronary arteries with a microcirculation; and an interstitium composed largely of fibrillar collagen. As long as intercompartmental equilibrium exists, myocardial mechanics and energetics and myocyte viability will each be preserved.

2 The hypertrophic process seen with left ventricular pressure overload secondary to renovascular hypertension alters this equilibrium because of the adverse remodelling of intramural coronary arteries and fibrillar collagen. The pathogenetic mechanism(s) responsible for the observed myocardial fibrosis, having reactive and reparative components, remains to be elucidated.

3 Attractive circumstantial evidence, however, has been obtained to incriminate circulating angiotensin II in this process. Five lines of evidence favouring the role of angiotensin II in promoting the reactive perivascular and interstitial fibrosis and the reparative fibrosis are presented, including the potential cardioprotective effects of angiotensin converting enzyme inhibitors.

Keywords: angiotensin, myocardium

Full text

PDF

Images in this article

142SFigure 1
on p.142S
143SFigure 2
on p.143S
146SFigure 5
on p.146S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrahams C., Janicki J. S., Weber K. T. Myocardial hypertrophy in Macaca fascicularis. Structural remodeling of the collagen matrix. Lab Invest. 1987 Jun;56(6):676–683. [PubMed] [Google Scholar]
  2. Anderson K. R., Sutton M. G., Lie J. T. Histopathological types of cardiac fibrosis in myocardial disease. J Pathol. 1979 Jun;128(2):79–85. doi: 10.1002/path.1711280205. [DOI] [PubMed] [Google Scholar]
  3. Anversa P., Hiler B., Ricci R., Guideri G., Olivetti G. Myocyte cell loss and myocyte hypertrophy in the aging rat heart. J Am Coll Cardiol. 1986 Dec;8(6):1441–1448. doi: 10.1016/s0735-1097(86)80321-7. [DOI] [PubMed] [Google Scholar]
  4. Averill D. B., Ferrario C. M., Tarazi R. C., Sen S., Bajbus R. Cardiac performance in rats with renal hypertension. Circ Res. 1976 Apr;38(4):280–288. doi: 10.1161/01.res.38.4.280. [DOI] [PubMed] [Google Scholar]
  5. Bhan R. D., Giacomelli F., Wiener J. Ultrastructure of coronary arteries and myocardium in experimental hypertension. Exp Mol Pathol. 1978 Aug;29(1):66–81. doi: 10.1016/0014-4800(78)90027-8. [DOI] [PubMed] [Google Scholar]
  6. Caspari P. G., Newcomb M., Gibson K., Harris P. Collagen in the normal and hypertrophied human ventricle. Cardiovasc Res. 1977 Nov;11(6):554–558. doi: 10.1093/cvr/11.6.554. [DOI] [PubMed] [Google Scholar]
  7. Cheitlin M. D., Robinowitz M., McAllister H., Hoffman J. I., Bharati S., Lev M. The distribution of fibrosis in the left ventricle in congenital aortic stenosis and coarctation of the aorta. Circulation. 1980 Oct;62(4):823–830. doi: 10.1161/01.cir.62.4.823. [DOI] [PubMed] [Google Scholar]
  8. Doering C. W., Jalil J. E., Janicki J. S., Pick R., Aghili S., Abrahams C., Weber K. T. Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res. 1988 Oct;22(10):686–695. doi: 10.1093/cvr/22.10.686. [DOI] [PubMed] [Google Scholar]
  9. GIESE J. ACUTE HYPERTENSIVE VASCULAR DISEASE. 1. RELATION BETWEEN BLOOD PRESSURE CHANGES AND VASCULAR LESIONS IN DIFFERENT FORMS OF ACUTE HYPERTENSION. Acta Pathol Microbiol Scand. 1964;62:481–496. doi: 10.1111/apm.1964.62.4.481. [DOI] [PubMed] [Google Scholar]
  10. GIESE J. ACUTE HYPERTENSIVE VASCULAR DISEASE. 2. STUDIES ON VASCULAR REACTION PATTERNS AND PERMEABILITY CHANGES BY MEANS OF VITAL MICROSCOPY AND COLLOIDAL TRACER TECHNIQUE. Acta Pathol Microbiol Scand. 1964;62:497–515. doi: 10.1111/apm.1964.62.4.497. [DOI] [PubMed] [Google Scholar]
  11. Giacomelli F., Anversa P., Wiener J. Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium. Am J Pathol. 1976 Jul;84(1):111–138. [PMC free article] [PubMed] [Google Scholar]
  12. Grove D., Zak R., Nair K. G., Aschenbrenner V. Biochemical correlates of cardiac hypertrophy. IV. Observations on the cellular organization of growth during myocardial hypertrophy in the rat. Circ Res. 1969 Oct;25(4):473–485. doi: 10.1161/01.res.25.4.473. [DOI] [PubMed] [Google Scholar]
  13. Hess O. M., Schneider J., Koch R., Bamert C., Grimm J., Krayenbuehl H. P. Diastolic function and myocardial structure in patients with myocardial hypertrophy. Special reference to normalized viscoelastic data. Circulation. 1981 Feb;63(2):360–371. doi: 10.1161/01.cir.63.2.360. [DOI] [PubMed] [Google Scholar]
  14. Jalil J. E., Doering C. W., Janicki J. S., Pick R., Clark W. A., Abrahams C., Weber K. T. Structural vs. contractile protein remodeling and myocardial stiffness in hypertrophied rat left ventricle. J Mol Cell Cardiol. 1988 Dec;20(12):1179–1187. doi: 10.1016/0022-2828(88)90597-4. [DOI] [PubMed] [Google Scholar]
  15. Jalil J. E., Doering C. W., Janicki J. S., Pick R., Shroff S. G., Weber K. T. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res. 1989 Jun;64(6):1041–1050. doi: 10.1161/01.res.64.6.1041. [DOI] [PubMed] [Google Scholar]
  16. Kannel W. B., Levy D., Cupples L. A. Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study. J Cardiovasc Pharmacol. 1987;10 (Suppl 6):S135–S140. [PubMed] [Google Scholar]
  17. Laine G. A. Microvascular changes in the heart during chronic arterial hypertension. Circ Res. 1988 May;62(5):953–960. doi: 10.1161/01.res.62.5.953. [DOI] [PubMed] [Google Scholar]
  18. Lindy S., Turto H., Uitto J. Protocollagen proline hydroxylase activity in rat heart during experimental cardiac hypertrophy. Circ Res. 1972 Feb;30(2):205–209. doi: 10.1161/01.res.30.2.205. [DOI] [PubMed] [Google Scholar]
  19. Marcus M. L., Mueller T. M., Gascho J. A., Kerber R. E. Effects of cardiac hypertrophy secondary to hypertension on the coronary circulation. Am J Cardiol. 1979 Oct 22;44(5):1023–1028. doi: 10.1016/0002-9149(79)90239-x. [DOI] [PubMed] [Google Scholar]
  20. Marino T. A., Kent R. L., Uboh C. E., Fernandez E., Thompson E. W., Cooper G., 4th Structural analysis of pressure versus volume overload hypertrophy of cat right ventricle. Am J Physiol. 1985 Aug;249(2 Pt 2):H371–H379. doi: 10.1152/ajpheart.1985.249.2.H371. [DOI] [PubMed] [Google Scholar]
  21. Michel J. B., Dussaule J. C., Choudat L., Auzan C., Nochy D., Corvol P., Menard J. Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats. Kidney Int. 1986 May;29(5):1011–1020. doi: 10.1038/ki.1986.101. [DOI] [PubMed] [Google Scholar]
  22. Michel J. B., Salzmann J. L., Ossondo Nlom M., Bruneval P., Barres D., Camilleri J. P. Morphometric analysis of collagen network and plasma perfused capillary bed in the myocardium of rats during evolution of cardiac hypertrophy. Basic Res Cardiol. 1986 Mar-Apr;81(2):142–154. doi: 10.1007/BF01907379. [DOI] [PubMed] [Google Scholar]
  23. Moe G. W., Stopps T. P., Angus C., Forster C., De Bold A. J., Armstrong P. W. Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure. J Am Coll Cardiol. 1989 Jan;13(1):173–179. doi: 10.1016/0735-1097(89)90567-6. [DOI] [PubMed] [Google Scholar]
  24. Morkin E., Ashford T. P. Myocardial DNA synthesis in experimental cardiac hypertrophy. Am J Physiol. 1968 Dec;215(6):1409–1413. doi: 10.1152/ajplegacy.1968.215.6.1409. [DOI] [PubMed] [Google Scholar]
  25. Naeye R. L., Liedtke A. J. Consequences of intramyocardial arterial lesions in aortic valvular stenosis. Am J Pathol. 1976 Dec;85(3):569–580. [PMC free article] [PubMed] [Google Scholar]
  26. Oldershaw P. J., Brooksby I. A., Davies M. J., Coltart D. J., Jenkins B. S., Webb-Peploe M. M. Correlations of fibrosis in endomyocardial biopsies from patients with aortic valve disease. Br Heart J. 1980 Dec;44(6):609–611. doi: 10.1136/hrt.44.6.609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pearlman E. S., Weber K. T., Janicki J. S., Pietra G. G., Fishman A. P. Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab Invest. 1982 Feb;46(2):158–164. [PubMed] [Google Scholar]
  28. Riegger G. A., Liebau G., Holzschuh M., Witkowski D., Steilner H., Kochsiek K. Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade. Am J Cardiol. 1984 Feb 1;53(4):614–618. doi: 10.1016/0002-9149(84)90040-7. [DOI] [PubMed] [Google Scholar]
  29. Schaper J., Schaper W. Ultrastructural correlates of reduced cardiac function in human heart disease. Eur Heart J. 1983 Jan;4 (Suppl A):35–42. doi: 10.1093/eurheartj/4.suppl_a.35. [DOI] [PubMed] [Google Scholar]
  30. Schwarz F., Flameng W., Schaper J., Hehrlein F. Correlation between myocardial structure and diastolic properties of the heart in chronic aortic valve disease: effects of corrective surgery. Am J Cardiol. 1978 Dec;42(6):895–903. doi: 10.1016/0002-9149(78)90673-2. [DOI] [PubMed] [Google Scholar]
  31. Sen S., Bumpus F. M. Collagen synthesis in development and reversal of cardiac hypertrophy in spontaneously hypertensive rats. Am J Cardiol. 1979 Oct 22;44(5):954–958. doi: 10.1016/0002-9149(79)90228-5. [DOI] [PubMed] [Google Scholar]
  32. Sen S., Tarazi R. C., Bumpus F. M. Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats. Hypertension. 1980 Mar-Apr;2(2):169–176. doi: 10.1161/01.hyp.2.2.169. [DOI] [PubMed] [Google Scholar]
  33. Sen S., Tarazi R. C., Bumpus F. M. Reversal of cardiac hypertrophy in renal hypertensive rats: medical vs. surgical therapy. Am J Physiol. 1981 Mar;240(3):H408–H412. doi: 10.1152/ajpheart.1981.240.3.H408. [DOI] [PubMed] [Google Scholar]
  34. Skosey J. L., Zak R., Martin A. F., Aschenbrenner V., Rabinowitz M. Biochemical correlates of cardiac hypertrophy. V. Labeling of collagen, myosin, and nuclear DNA during experimental myocardial hypertrophy in the rat. Circ Res. 1972 Aug;31(2):145–157. doi: 10.1161/01.res.31.2.145. [DOI] [PubMed] [Google Scholar]
  35. St John Sutton M. G., Lie J. T., Anderson K. R., O'Brien P. C., Frye R. L. Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. Br Heart J. 1980 Oct;44(4):433–443. doi: 10.1136/hrt.44.4.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tanaka M., Fujiwara H., Onodera T., Wu D. J., Hamashima Y., Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J. 1986 Jun;55(6):575–581. doi: 10.1136/hrt.55.6.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Tanaka M., Fujiwara H., Onodera T., Wu D. J., Matsuda M., Hamashima Y., Kawai C. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation. 1987 Jun;75(6):1130–1139. doi: 10.1161/01.cir.75.6.1130. [DOI] [PubMed] [Google Scholar]
  38. Thiedemann K. U., Holubarsch C., Medugorac I., Jacob R. Connective tissue content and myocardial stiffness in pressure overload hypertrophy. A combined study of morphologic, morphometric, biochemical, and mechanical parameters. Basic Res Cardiol. 1983 Mar-Apr;78(2):140–155. doi: 10.1007/BF01906668. [DOI] [PubMed] [Google Scholar]
  39. Turto H. Collagen metabolism in experimental cardiac hypertrophy in the rat and the effect of digitoxin treatment. Cardiovasc Res. 1977 Jul;11(4):358–366. doi: 10.1093/cvr/11.4.358. [DOI] [PubMed] [Google Scholar]
  40. Weber K. T., Janicki J. S., Shroff S. G., Pick R., Chen R. M., Bashey R. I. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res. 1988 Apr;62(4):757–765. doi: 10.1161/01.res.62.4.757. [DOI] [PubMed] [Google Scholar]
  41. Wiener J., Giacomelli F. The cellular pathology of experimental hypertension. 7. Structure and permeability of the mesenteric vasculature in angiotensin-induced hypertension. Am J Pathol. 1973 Aug;72(2):221–231. [PMC free article] [PubMed] [Google Scholar]
  42. Wiener J., Lattes R. G., Meltzer B. G., Spiro D. The cellular pathology of experimental hypertension. IV. Evidence for increased vascular permeability. Am J Pathol. 1969 Feb;54(2):187–207. [PMC free article] [PubMed] [Google Scholar]
  43. Wikman-Coffelt J., Parmley W. W., Mason D. T. The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development. Circ Res. 1979 Dec;45(6):697–707. doi: 10.1161/01.res.45.6.697. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES